
AstraZeneca PLC
LSE:AZN

Intrinsic Value
The intrinsic value of one
AZN
stock under the Base Case scenario is
13 242.78
GBX.
Compared to the current market price of 10 240 GBX,
AstraZeneca PLC
is
Undervalued by 23%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
AstraZeneca PLC
Fundamental Analysis


Revenue & Expenses Breakdown
AstraZeneca PLC
Balance Sheet Decomposition
AstraZeneca PLC
Current Assets | 26.1B |
Cash & Short-Term Investments | 5.4B |
Receivables | 14.8B |
Other Current Assets | 5.9B |
Non-Current Assets | 80.1B |
Long-Term Investments | 1.9B |
PP&E | 12.3B |
Intangibles | 58.7B |
Other Non-Current Assets | 7.2B |
Free Cash Flow Analysis
AstraZeneca PLC
USD | |
Free Cash Flow | USD |
Earnings Waterfall
AstraZeneca PLC
Revenue
|
55B
USD
|
Cost of Revenue
|
-9.7B
USD
|
Gross Profit
|
45.3B
USD
|
Operating Expenses
|
-32.1B
USD
|
Operating Income
|
13.2B
USD
|
Other Expenses
|
-5.5B
USD
|
Net Income
|
7.8B
USD
|
AZN Profitability Score
Profitability Due Diligence
AstraZeneca PLC's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Score
AstraZeneca PLC's profitability score is 63/100. The higher the profitability score, the more profitable the company is.
AZN Solvency Score
Solvency Due Diligence
AstraZeneca PLC's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Score
AstraZeneca PLC's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AZN Price Targets Summary
AstraZeneca PLC
According to Wall Street analysts, the average 1-year price target for
AZN
is 13 528.42 GBX
with a low forecast of 6 864.74 GBX and a high forecast of 18 270 GBX.
Dividends
Current shareholder yield for AZN is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
AZN
stock under the Base Case scenario is
13 242.78
GBX.
Compared to the current market price of 10 240 GBX,
AstraZeneca PLC
is
Undervalued by 23%.